Revolution Medicines, Inc.
Key Metrics
Market Snapshot
About
Revolution Medicines, Inc. is a clinical-stage precision oncology company developing targeted therapies for RAS-addicted cancers. The company focuses on creating innovative small molecule drugs that address difficult-to-treat cancers driven by RAS mutations, one of the most common oncogenic drivers. Revolution Medicines utilizes a structure-based drug design platform to advance multiple programs through clinical development.